
You can purchase shares of Bambusa Therapeutics (NASDAQ:BBTX) through any online brokerage.
There are no as such competitors for Bambusa Therapeutics.
There is no analysis for Bambusa Therapeutics to provide a consensus price target.
The stock price for Bambusa Therapeutics (NASDAQ: BBTX) is $15.8501 last updated November 3, 2026 at 7:36 PM EST.
There are no upcoming dividends for Bambusa Therapeutics.
Bambusa Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bambusa Therapeutics.
Bambusa Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.
Bambusa Therapeutics Inc is a clinical-stage biotechnology company developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases.